Clinical Trials Sponsored by Spherix Incorporated

Total 1225 results

Proacta, Incorporated

Terminated

Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

United States, Taiwan, Singapore, Hong Kong
Cebix Incorporated

Completed

Safety and Pharmacokinetics of CBX129801 in Patients With Type 1 Diabetes

Diabetes Mellitus | Type 1 Diabetes | Peripheral Diabetic Neuropathy

United States
Proacta, Incorporated

Terminated

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Lung Cancer

United States
Proacta, Incorporated

Unknown

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia

United States
Genta Incorporated

Unknown

Tesetaxel as First-line Therapy for Metastatic Breast Cancer

Breast Neoplasm

United States
Genta Incorporated

Unknown

Study of Tesetaxel in Japanese Patients With Solid Tumors

Advanced Solid Tumors

Japan
Genta Incorporated

Completed

Pharmacokinetic Study of Genasense in Subjects With Normal Renal Function, Mildly Impaired Renal Function, and Moderately Impaired Renal Function

Normal Renal Function | Mildly Impaired Renal Function | Moderately Impaired Renal Function

United States
Hollister Incorporated

Completed

Preliminary Evaluation of CASTLE Barrier North American Prototype

Peristomal Skin Complication

United States, Canada
Genta Incorporated

Unknown

Tesetaxel as Second-line Therapy for Patients With Advanced Melanoma and Normal Serum LDH

Melanoma

United States
Genta Incorporated

Completed

Genasense® (Oblimersen Sodium), Fludarabine, and Rituximab in Subjects With Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia

United States
Genta Incorporated

Completed

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma (AGENDA)

Melanoma

United States, France, United Kingdom, Spain, Switzerland, Australia, Canada, Germany, Poland, Italy, Austria, Czech Republic
LensAR Incorporated

Unknown

Laser Treatment of the Crystalline Lens

Cataract

Mexico
LensAR Incorporated

Unknown

Prospective Clinical Trial of the LensAR Laser System

Cataract

Mexico
Genta Incorporated

Withdrawn

This Study is Being Performed to Evaluate the Effect of Genasense on the Efficacy and the Safety of Rituximab/Fludarabine Combination Treatment in Previously Untreated Subjects With Chronic Lymphocyctic Leukemia(CLL)

Lymphocytic Leukemia
Genta Incorporated

Completed

A Phase I Study of G3139 Subcutaneous in Solid Tumors

Tumors

United States
Cook Research Incorporated

Not yet recruiting

EchoTip AcuCore Post-Market Clinical Study

Adenocarcinoma | Hepatocellular Carcinoma | Neuroendocrine Tumors | Cholangiocarcinoma | Metastasis | Chronic Pancreatitis | Autoimmune Pancreatitis | Malignant Lymphoma
Cook Research Incorporated

Recruiting

Zenith Thoracic Alpha (ZTA) Post-Market Data Collection

Thoracic Aortic Aneurysm | Penetrating Aortic Ulcer

France, Germany
Cook Research Incorporated

Not yet recruiting

Post-Market Celect Platinum Vena Cava Filter and Gunther Tulip Retrieval Set Study

Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolism
Cook Research Incorporated

Completed

Post-market Assessment of Biodesign Dural Repair Grafts

Cerebrospinal Fluid Leak

Canada, United States, Italy
Cook Research Incorporated

Completed

Fenestrated AAA Endovascular Graft Post-Approval Study

Abdominal Aortic Aneurysm (AAA) | Aorto-iliac Aneurysm | Juxtarenal Aneurysm

United States
Cook Research Incorporated

Completed

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study

Iliac Aneurysms | Aortoiliac Aneurysms

United States
Cook Research Incorporated

Completed

VIVO Clinical Study

Symptomatic Venous Outflow Obstruction in the Iliofemoral Vein

United States, Taiwan
Cook Research Incorporated

No longer available

PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation

Iliac Aneurysms | Aortoiliac Aneurysms

United States
Cook Research Incorporated

Approved for marketing

Zenith® Dissection Endovascular System in the Treatment of Patients With Aortic Dissections

Aortic Dissection

United States
Cook Research Incorporated

Recruiting

European Aortic Data Collection Project (EADC)

Thoracoabdominal Aortic Aneurysm | Aortic Arch Aneurysm | Complex Abdominal Aortic Aneurysm | Chronic Aortic Dissection

Denmark, France, Germany
Cook Research Incorporated

Active, not recruiting

Zenith® p-Branch® Endovascular Graft Pivotal Study

Aortic Aneurysm Abdominal

United States
Cook Research Incorporated

Completed

Flourish™ Pediatric Esophageal Atresia

Digestive System Abnormalities | Esophageal Atresia | Esophageal Disorders Congenital

United States, Canada
Cook Research Incorporated

Completed

Zenith® Low Profile AAA Endovascular Graft

Abdominal Aortic Aneurysms | Iliac Aneurysms | Aortoiliac Aneurysms

United States, Canada
Cook Research Incorporated

Completed

Cook IVC Filter Study (CIVC)

Pulmonary Embolism

United States, Australia, United Kingdom
Cook Research Incorporated

Completed

TX2® Low Profile TAA Endovascular Graft (TX2® LP)

Aortic Aneurysm | Vascular Disease | Penetrating Ulcer

United States, Japan, Germany, Italy, Sweden, United Kingdom
Cook Research Incorporated

Completed

Zenith Alpha™ Abdominal Endovascular Graft

Aorto-iliac Aneurysm | Abdominal Aortic

Canada
Cook Research Incorporated

Completed

Zenith® p-Branch® OTS Multicenter Study

Aortic Aneurysm, Abdominal

United States
Cook Research Incorporated

Completed

TRANSFIX Zenith® Transection Clinical Study (TRANSFIX)

Thoracic Injuries | Thoracic Aorta | Blunt Injuries

United States
Cook Research Incorporated

Completed

Transvenous Lead Removal Post-Market Clinical Study

Cardiac Electrophysiology

United States, Netherlands, Germany, United Kingdom
Soterix Medical
Columbia University

Recruiting

Virtual Neuro-Navigation System for Personalized Community Based TMS

Treatment Resistant Depression

United States
Insmed Incorporated

Completed

A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease

Pulmonary Hypertension

Belgium, Germany, Spain, Argentina, Australia, Italy, United Kingdom
Lenstec Incorporated

Completed

Clinical Evaluation of the Lenstec Softec HP1 Intraocular Lens

Aphakia

United Kingdom
Insmed Incorporated

Completed

Single Dose Escalation Study of TR02 (Sustained Lipid Inhalation Technology [SLIT™] Amikacin) in Participants With Cystic Fibrosis (CF) Having Chronic Infections of Pseudomonas Aeruginosa

Cystic Fibrosis
Insmed Incorporated

Completed

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of C16TR for Inhalation With Tyvaso® Cohort in Healthy Participants

Healthy Volunteers

United States
Insmed Incorporated

Completed

A Study to Investigate Lung Deposition of Inhaled Amikacin-loaded Liposomes in Healthy Male Participants

Healthy Volunteers
Celularity Incorporated

Active, not recruiting

Natural Killer Cell (CYNK-001) Infusions in Adults With Multiple Myeloma

Cardiovascular Diseases | Vascular Diseases | Neoplasms | Immune System Diseases | Neoplasms by Histologic Type | Lymphoproliferative Disorders | Immunoproliferative Disorders | Hematologic Diseases | Hemorrhagic Disorders | Multiple Myeloma | Paraproteinemias | Blood Protein Disorders | Antineoplastic Agents | Physiological... and other conditions

United States
Celularity Incorporated

Withdrawn

CYNK-001 IV and IC in Combination With IL2 in Surgical Eligible Recurrent GBM With IDH-1 Wild Type (CYNK001GBM02)

Glioblastoma | Glioblastoma Multiforme | Giant Cell Glioblastoma | Astrocytoma, Grade IV

United States
Celularity Incorporated

Completed

A Efficacy and Safety Study of Intramuscular Injection of Human Placenta-Derived Cells (PDA-002) in Subjects With Diabetic Peripheral Neuropathy

Peripheral Nervous System Diseases | Diabetic Nephropathies

United States
Insmed Incorporated

Completed

Multidose Safety and Tolerability Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKACE™)

Cystic Fibrosis

Poland, Ukraine, Serbia, Belgium, Hungary, Slovakia, North Macedonia
Celularity Incorporated

Terminated

A Safety Study of Human Cord Blood Derived, Culture Expanded Natural Killer Cell (PNK-007) Infusion With Subcutaneous Recombinant Human IL-2 (rhIL-2) in Adults With Relapsed and/or Refractory Acute Myeloid Leukemia (AML)

Leukemia, Myeloid, Acute

United States
Insmed Incorporated

Completed

Study to Evaluate Arikayce™ in CF Patients With Chronic Pseudomonas Aeruginosa Infections

Pseudomonas Aeruginosa Infection

France, Poland, United Kingdom, Germany, Spain, Belgium, Bulgaria, Denmark, Greece, Canada, Netherlands, Hungary, Italy, Ireland, Sweden, Slovakia, Austria, Serbia
Hollister Incorporated

Completed

Assessment of an Oral Endotracheal Subglottic Tube Holder

Intubation

United States
Insmed Incorporated

Completed

Safety/Tolerability Study of Arikayce™ in Cystic Fibrosis Patients With Chronic Infection Due to Pseudomonas Aeruginosa

Cystic Fibrosis

United States
Lenstec Incorporated

Completed

Lenstec Tetraflex Accommodating Posterior Chamber Intraocular Lens (IOL) Clinical Investigation

Cataract
Lenstec Incorporated

Terminated

Visual and Refractive Outcomes After Implantation of Aspheric IOLs With Different Dioptric Increments and Manufacturing

Cataract

United States

Clinical Trials Sponsored by Spherix Incorporated

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Luxembourg

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations